000	00000cam 2200000zi 4500
001	9.961556
003	CaOODSP
005	20260605125558
006	m     o  d f
007	cr cn ||||||||
008	260331e202603##onca    ob   f000 0 eng d
020	|a9780660993539
040	|aCaOODSP|beng|erda|cCaOODSP
043	|an-cn---
086	1 |aHP45-41/2026E-PDF
245	00|aRisk management for dual-use potential in life science research.
246	17|aCanadian biosafety guideline
264	1|aOttawa : |bGovernment of Canada = Gouvernement du Canada, |cMarch 2026.
264	4|c©2026
300	|a1 online resource (viii, 49 pages) : |billustrations
336	|atext|btxt|2rdacontent
337	|acomputer|bc|2rdamedia
338	|aonline resource|bcr|2rdacarrier
500	|aIssued also in French under title: Gestion des risques associés à la possibilté de double usage dans la recherche en sciences de la vie.
504	|aIncludes bibliographical references.
520	|a"The Risk Management for Dual-Use Potential in Life Science Research guideline was developed by PHAC and CFIA as part of a series of electronic publications that expand upon the biosafety and biosecurity concepts discussed in the Canadian Biosafety Standard, Third Edition (CBS). This guideline provides information and considerations on how to assess dual use potential in life science research involving pathogens, toxins, or other biological material, and how to manage associated risks"--page v.
650	0|aBiosecurity|xGovernment policy|zCanada.
650	0|aBiosecurity|xRisk assessment|zCanada.
650	0|aLife sciences|xResearch|xRisk assessment|zCanada.
710	2 |aPublic Health Agency of Canada, |eissuing body.
775	08|tGestion des risques associés à la possibilté de double usage dans la recherche en sciences de la vie.|w(CaOODSP)9.961557
856	40|qPDF|s8.07 MB|uhttps://publications.gc.ca/collections/collection_2026/aspc-phac/HP45-41-2026-eng.pdf
856	4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/canadian-biosafety-standards-guidelines/guidance/risk-management-dual-use-potential-life-science-research.html
986	|a250505